To investigate how T cells recognize allogeneic class I proteins encoded by the major histocompatibility complex (MHC), we examined the human cytotoxic T lymphocytes (CTL) elicited in a mixed lymphocyte reaction against a lymphoblastoid B-cell line (JY) whose MHC-class I proteins are HLA-A2 and -B7. By panning the responding T cells on plates that were coated with purified HLA-A2, an essentially pure population of CD8+ anti-HLA-A2 CTL was isolated in a single step and established as a cell line designated A2p. In addition to lysing HLA-A2' target cells, the A2p cells lysed HLA-A2-cells, including mouse cells (P815), when purified native HLA-A2 was attached to them, but not when denatured HLA-A2 was attached. Thus, contrary to the general rule that T cells recognize sequential antigenic determinants in denatured protein antigens, the alloreactive CTLs appear to recognize determinants that depend upon the native configuration of HLA-A2; however, the possibility that these T cells recognize a peptide adduct persistently associated with purified, soluble HLA-A2 has not been ruled out. . We show that from the resulting mixed lymphocyte response, it was possible to isolate CTL specific for HLA-A2 as an essentially pure cell population by adsorbing them on plastic plates to which purified HLA-A2 had itself been previously adsorbed. The isolated CTL specifically killed HLA-A2-bearing human cells and also cells of a mouse cell line (P815) to which purified HLA-A2 was attached. Since P815 cells were not lysed when denatured HLA-A2 (DA2) was attached to them, the native configuration of HLA-A2 appears to be required for its recognition by alloreactive CTL.
HLA-A2-cells, including mouse cells (P815), when purified native HLA-A2 was attached to them, but not when denatured HLA-A2 was attached. Thus, contrary to the general rule that T cells recognize sequential antigenic determinants in denatured protein antigens, the alloreactive CTLs appear to recognize determinants that depend upon the native configuration of HLA-A2; however, the possibility that these T cells recognize a peptide adduct persistently associated with purified, soluble HLA-A2 has not been ruled out.
B cells interact with antigens in solution or on a cell surface, but a T cell typically reacts only with antigens on another cell (the target or antigen-presenting cell) on which peptide fragments of protein antigens are associated with glycoproteins encoded by genes of the major histocompatibility complex (MHC). The associated MHC proteins are normally the same ("self") on the other cell and on the T cell, and yet individual clones of T cells almost invariably also react specifically with one or more foreign (allogeneic) MHC proteins. These alloreactions underlie such diverse phenomena as rejection of allografts, graft-versus-host disease in recipients of bone marrow transplants, and proliferation of T cells in mixed lymphocyte cultures (MLCs). To define the nature of the antigenic determinants (epitopes) that are recognized by T cells on allogeneic MHC glycoproteins, we have examined the reactions of CD8+ cytotoxic T lymphocytes (CTL) with purified class I MHC glycoproteins (termed "MHC-I protein").*
The CTL were generated in a MLC prepared by incubating irradiated cells of an Epstein-Barr virus-transformed B-cell line (JY) with peripheral blood lymphocytes (PBL) from an individual who lacked the MHC-I proteins on JY cells, HLA-A2 and HLA-B7. We show that from the resulting mixed lymphocyte response, it was possible to isolate CTL specific for HLA-A2 as an essentially pure cell population by adsorbing them on plastic plates to which purified HLA-A2 had itself been previously adsorbed. The isolated CTL specifically killed HLA-A2-bearing human cells and also cells of a mouse cell line (P815) to which purified HLA-A2 was attached. Since P815 cells were not lysed when denatured HLA-A2 (DA2) was attached to them, the native configuration of HLA-A2 appears to be required for its recognition by alloreactive CTL.
MATERIALS AND METHODS
Antibodies. Hybridomas purchased from American Type Culture Collection were grown as ascites tumors in pristaneprimed BALB/c mice to produce the following monoclonal antibodies (mAbs): OKT3 (anti-human CD3), OKT4 (antihuman CD4), OKT8 (anti-human CD8), BB 7.1 (anti-HLA-B7), BB 7.2 (anti-HLA-A2), PA 2.1 (anti-HLA-A2,A28), MA 2.1 (anti-HLA-A2,B17). The monoclonal immunoglobulins were precipitated from ascites fluid by ammonium sulfate and purified by anion-exchange chromatography (2) . mAb WT31, recognizing an invariant determinant of the T-cell antigen af3-chain receptor-CD3 complex, was purchased from Beckton Dickinson, and mAb 3G8 (anti-human CD16) was kindly provided by J. Unkeless (Mt. Sinai Hospital School of Medicine, New York).
Polyclonal rabbit antiserum to human 82-microglobulin (32m) was purchased from Miles, and affinity-purified goat antibodies to mouse Fc fragment was obtained from ICN Immunobiologicals (Lisle, IL). Fluorescein isothiocyanatelabeled, affinity-purified goat antibodies to mouse IgG and to rabbit IgG were from Kirkegaard and Perry (Gaithersburg, MD).
Cell Lines. The cell lines used were K-562 (MHC class I-negative), four human lymphoblastoid B-cell lines [JY (HLA-A2,A2,B7,B7), CCRF-SB (HLA-A1,A2,B12,B17, Cw2), RPMI 7666 (HLA-A3,Aw29,B7,B12), and Daudi (MHC class I-negative)], and the murine mastocytoma cell line P815. Cells were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum. The cell lines CCRF-SB and RPMI 7666 were obtained from the American Type Culture Collection.
MLC. PBL were isolated from fresh venous blood by density centrifugation on Ficoll-Paque (Pharmacia, Uppsala); 1 x 107 PBL were mixed with 1 x 107 irradiated (6000 rads; 1 rad = 0.01 Gy) JY cells in a total volume of 30 ml and incubated upright in a 75-cm2 Falcon tissue culture flask at 370C (5% C02/95% air). Maximum cytotoxicity against 51Cr-labeled JY was observed on day 7 .
Purification of HLA Antigens. HLA-A2 and -B7 were isolated from JY cells as described (3) ,ug/ml in the same buffer. After 30 min at 4°C, the cells were again washed three times and resuspended in 500 1,l of the same.
Preparation of Surrogate Targets. Streptavidin (Boehringer Mannheim) was covalently linked to HLA-A2 or -B7, and the complexes were added to biotinylated cells. To prepare HLA-streptavidin, HLA protein (1 mg/ml of 0.1 M NaCI/0.1 M phosphate, pH 7.5) was incubated with a 50 x molar excess of N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP) for 20 min at room temperature before exhaustive dialysis. An average of 2.5 titratable disulfide groups were incorporated per HLA molecule (HLASPDP).
Streptavidin was thiolated (streptavidin-SH) with a 150 x molar excess of Trauts reagent (2-iminothiolane; Pierce) and then passed through a Sephadex G-25 column (0.9 x 5 cm) equilibrated with nitrogen-saturated PBS. Streptavidin-SH and HLASPDP, in equimolar amounts, were incubated for 4 hr at room temperature, and nonconjugated streptavidin was removed by immunoaffinity chromatography on a Sephadex 4B-BB 7.2 (or BB 7.1) column. The eluted material (containing streptavidin-HLA and free HLA) was dialyzed against PBS, and a small sample was analyzed by HPLC on a TSK Sepherogel 4000 SW column (Beckman). The jug/ml) for 30 min on ice, followed by three washes in RPMI 1640 medium/10% fetal calf serum.
RESULTS AND DISCUSSION
Specific Adherence to Antigen-Coated Plates. To demonstrate a specific interaction between purified HLA-A2 and alloreactive cells generated in an MLC of HLA-A2-negative PBL against JY cells (HLA-A2' ,B7+), we determined whether the alloreactive cells would adhere specifically to plates coated with HLA-A2 (a process generally referred to as "panning"; refs. 5 and 6). Nonspecific adherence was monitored on wells coated with ovalbumin, and efficiency of adsorption was estimated from the adherence of cells previously coated with antibodies to the T-cell receptor (wT31) or to CD8 (OKT8) to wells on which goat antibodies to the Fc domain of mouse Ig had been adsorbed. The proportion of cells that adhered was 0.8 + 0.1%, 10.0 ± 3.0%, 14.0 + 3.0%, and 8.0 ± 2.0o for wells coated with ovalbumin, wT31, OKT8, and HLA-A2, respectively. Thus, it appeared that, despite a low overall adsorption efficiency (probably due to uneven setting of cells in the wells), a significant proportion of cells in the MLC were capable of binding to purified HLA-A2 adsorbed to plastic.
When cells were returned to the wells in which they had been selected and cultured for 5 days in medium supplemented with lymphokines, they clearly proliferated ( Fig. 1) : those adsorbed on wT31 and on HLA-A2 underwent around five cycles of division, whereas control cells, adsorbed on ovalbumin, did not proliferate significantly. Cells adsorbed on OKT8 underwent around two divisions and did not divide further unless irradiated JY cells were added as a specific stimulus (results not shown). It has been shown that anti-Tcell receptor antibodies can induce proliferation of helper T cells (7, 8) , whereas OKT8 (anti-CD8) seems not to have the same effect. Hence, it appears that the cells selected on HLA-A2 proliferated in response to specific interaction of their T-cell receptors with the adsorbed HLA-A2. These results do not preclude the involvement of accessory molecules (e.g., CD8) in the adhesion step, though the behavior of cells adsorbed on OKT8 suggests that the binding of CD8 alone is not sufficient to induce proliferation.
Phenotypic Analysis of Adsorbed Cells. The phenotype of the cells in the MLC and of those isolated by selective adsorption were analyzed by fluorescence flow cytometry using primary antibodies to T-cell antigens. At day 10 in the unfractionated MLC, about 40% of the cells were CD4+,CD8-; 60% were CD4-,CD8+; and 90% stained positive with antibodies to the T-cell receptor-CD3 complex (wT31 and OKT3; see Table 1 ). A small fraction was positive for the Fc receptor (CD16+).
Like the unfractionated MLC, cells selected on wT31
were 40%o CD4+,CD8-and 60% CD4-,CD8+; but cells selected on OKT8 were considerably enriched (about 90%) for the CD3+,CD4-,CD8+ phenotype. A similar enrichment was seen for cells selected on HLA-A2 (Table 1) effectively lysed only those target cells that expressed HLA-A2 (JY and CCRF; Fig. 2 of natural killer-like activity, since these cells also lysed targets that express no MHC-encoded antigens (K562; results not shown). Such natural killer-like activity of CTL grown in cell culture in the presence of lymphokines has been described (9, 10) .
Characterization and Lysis of Surrogate Targets. To learn more about the minimum recognition requirements for triggering alloreactive CTL, xenogeneic cells (murine P815 mastocytoma cells) were prepared as surrogate targets by linking purified HLA to them via a streptavidin-biotin bridge.
To ensure that the linking procedure did not damage the MHC proteins and to estimate their relative surface density on cells to which they were attached, the surrogate targets were analyzed by fluorescence-activated cell sorting with polyclonal antibodies to human /32m and a panel of MHC class I-specific mAbs. The HLA-A2 surrogates (designated P815-A2) were clearly reactive with the anti-HLA-A2 antibodies in the panel as well as with antibodies to 82m, but did not react with the antibody to HLA-B7 (BB 7.1). Conversely, HLA-B7-surrogates (designated P815-B7) reacted only with mAb 7.1 and antibodies to P2m (Table 2 ).
Because each of the three mAbs specific for diverse epitopes of HLA-A2 [MA 2.1 (11), BB 7.2 (12), and PA 2.1 (13)] reacted with P815-A2 cells, the structural integrity of the attached HLA-A2 must have been largely preserved, though some of the attached molecules may not be optimally oriented for reactivity with T cells.
A (1) (5) (2) 
Data were obtained by flow cytometry of natural and surrogate target cells using a panel of mAbs specific for HLA-A2 (BB 7.2, MA 2.1, PA 2.1) and HLA-B7 (BB 7.1), rabbit polyclonal antibodies against /32m (Ra,32m), and fluorescent anti-immunoglobulins. The fluorescence intensity values shown are means (in arbitrary units) of two or more independent analyses usually recorded at the same PMT gain setting. Below each of these values, the percentage of cells staining positive for each antibody (see the legend to Table 1) is given in parentheses. NT, not tested.
The ability of A2p cells to lyse 51Cr-labeled surrogate targets was examined in a 4-hr cytotoxicity assay at effector/target ratios of 50:1, 10:1, and 2:1. P815 cells to which antibodies to CD3 (OKT3) had been conjugated via a streptavidin-biotin bridge were used as a positive control (designated P815-OKT3). Here, both approximation of effector and target cells and subsequent triggering of the effector cells is brought about by binding of OKT3 to the T-cell receptor-CD3 complex of the effector cells. Biotinylated P815 cells coated with streptavidin were used as negative-control targets (designated P815-SA). Fig. 3 shows that P815-SA targets are not lysed by any of the CTL populations, whereas P815-OKT3 were lysed as efficiently as JY (Fig. 2) by each CTL population. A2p cells lysed P815-A2 targets but not P815-B7 targets, confirming the anti-HLA-A2 specificity of the A2p cell line. Both the unfractionated MLC and OKT8-panned cells lysed both P815-A2 and P815-B7 cells, indicating that the failure of A2p cells to lyse P815-B7 cells did not result from destruction of critical epitopes on the HLA-B7 molecule during the preparation of the surrogate target cells.
Lysis of P815-A2 by A2p cells was less effective than lysis of CCRF-SB (30% lysis achieved at an effector/target ratio of 40:1 compared to 10:1; cf. Figs. 2 and 3) , which may be a result of the lower surface density of HLA-A2 on surrogates than on CCRF-SB (Table 1 ). Another possibility is that lysis of human targets by human CTL may benefit from accessory "adhesion" molecules, such as the lymphocyte functionassociated antigens LFA-1 and -3 (14) , which are not present on P815 cells. However, it was shown that surrogate targets made with the MHC class I-negative human lymphoblastoid B-cell line Daudi, having the same surface density of HLA-A2, were no more efficiently lysed by A2p cells than were surrogates P815-A2 formed from the murine cells (data not shown).
Nevertheless, the lysis of P815-A2 targets by HLA-A2- the panel of mAb to HLA-A2 and found to be consistently nonreactive (Table 2) . Thus, though DA2 was present in adequate amounts on the surrogate cell surface, its conformation must have been extensively altered.
When A2p cells were tested against P815-DA2 targets (prepared from either reduced alkylated or guanidine HCItreated HLA-A2) in a 4-hr 51Cr-release assay, no lysis was observed, even at effector/target ratios as high as 50:1 (Fig.  4) . These results indicate that either recognition of P815-DA2 by A2p cells depends upon conformational determinants present in native but not DA2 molecules or that the DA2 no longer binds a critical peptide that is recognized by the anti-HLA-A2 CTLs.
CONCLUDING REMARKS
It is now widely accepted that both helper T cells and CTL recognize peptide fragments of protein antigens in conjunction with self MHC-I or -II glycoproteins, respectively. The recognition elements involved in alloreactivity are less-well understood. However, the fact that we could selectively adsorb alloreactive cells of a single specificity using a purified MHC-I antigen (HLA-A2) and that these cells lysed xenogeneic targets only if they were coated with purified HLA-A2 strongly supports the notion that the minimum recognition requirement for functional CTL alloreactivity is the allogeneic MHC-I molecule itself in the absence of other cell-surface molecules.
The possibility remains, however, that the purified HLA-A2 protein carries an associated peptide adduct and that the bimolecular complex is recognized by allogeneic CTL, as in a syngeneic (i.e., self-restricted) antigen-specific CTL response. Indeed, the recently described crystal structure of HLA-A2 reports the cocrystallization of "electron-dense material" in the putative antigen-binding pocket of the molecule, which could not be ascribed to the HLA-A2 primary sequence (16) . The dissociation of such an adduct from DA2 could account for the inactivity of guanidinetreated and reduced alkylated HLA-A2, provided that after several weeks in solution the isolated native HLA-A2 still retained significant amounts of the putative adduct. If sufficient amounts were not retained, our results imply that alloreactive CTL recognize the MHC-I molecule in its native configuration. The present system may provide opportunities to determine whether native MHC proteins, devoid of peptide adducts, can be recognized by T-cell receptors.
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